Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
NCT05701774· Phase 3· Soleno Therapeutics, Inc.· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error